Scopolamine usually is found to impair various aspects of human cognitive performance. Recently, however, a significant (though modest) improvement in verbal fluency has been reported following scopolamine hydrobromide (0.6 and 1.2 mg p.o.). This study replicated that effect, finding significantly better FAS letter fluency in contrast to poorer performance on other neuropsychological measures following sub cutaneous injection of 0.4 mg scopolamine. Data are discussed in terms of a functional state model of drug action.
Beatty W.W., Butters N., Janowsky D.S. (1986) Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neural Biol45: 196-211
2.
Caine ED, Weingartner H., Ludlow C.L., Cudahy E.A., Wehry S. (1981) Qualitative analysis of scopolamine-induced amnesia . Psychopharmacology74: 74-80
3.
Drachman D.A., Leavitt J. (1974) Human memory and the cholinergic system. Arch Neurol30: 113-121
4.
Dubois B., Danze F., Pillon B., Cusimano G., Lhermitte F., Agid Y. ( 1987) Cholinergic dependent cognitive deficits in Parkinson's Disease. Ann Neurol22: 26-30
5.
Dunne M.P. (1990) Scopolamine and sustained retrieval from semantic memory. J Psychopharmacol4: 13-18
6.
Dunne M.P., Hartley L.R. (1985) The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis. Acta Psychol58: 205-217
7.
Dunne M.P., Hartley L.R. (1986) Scopolamine and the control of attention in humans . Psychopharmacology89: 94-97
8.
Flicker C., Serby M., Ferris S.H. (1990) Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology100: 243-250
9.
Grant I., Atkinson J.H. (1990) The evolution of neuro-behavioural complications of HIV infection. Psychol Med20: 747-754
10.
Grant I., Heaton R.K. (1990) Human Immunodeficiency Virus—type 1 (HIV-1) and the brain. J Consulting Clin Psychol58: 22-30
11.
Hart S., Smith C.M., Swash M. (1988) Word fluency in patients with early dementia of Alzheimer type. Br J Clin Psychol27:115-124
12.
Kopelman M.D., Corn T.H. (1988) Cholinergic 'blockade' as a model for cholinergic depletion. Brain111: 1079-1110Lines C R., Preston G C., Broks P., Dawson C. (1991) The effects of scopolamine on retrieval from semantic memory. J Psychopharmacol5: 234-237
13.
Miller E. (1977) Abnormal ageing: the psychology of senile and presenile dementia. John Wiley & Sons, London
14.
Molchan S.E., Mellow A.M., Lawlor B.A., Weingartner H.J., Cohen R.M., Cohen M.R., Sunderland T. (1990) TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacology100: 84-89
15.
Preston G.C., Brazell C., Ward C., Broks P., Traub M., Stahl S.M. (1988) The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biological markers in man. J Psychopharmacol2: 67-79
16.
Spreen O., Strauss E. (1991) A compendium of neuropsychological tests. Oxford University Press, New York
17.
Sunderland T., Tariot P N., Cohen R M., Weingartner H., Mueller E A., Murphy D S. (1987) Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. Arch Gen Psychiatr44: 418-426
18.
Troster A.I., Beatty W.W., Staton R.D., Rorabaugh A.G. (1989) Effects of scopolamine on anterograde and remote memory in humans. Psychobiology17: 12-18
19.
Warburton D.M. (1986) A state model for mental effort. In Hockey G R J, Gaillard A W K, Coles M G H (eds), Energetics and human information processing. Martinus Nijhoff Publishers, Dordrecht, pp. 217-232
20.
Warburton D.M. (1987) Drugs and the processing of information. In Stahl S M, Iversen S D, Goodman E C (eds), Cognitive neurochemistry. Oxford University Press , Oxford, pp. 111-134
